RESUMO
INTRODUCTION: Sub-optimal joint function is extremely prevalent in dogs. Therefore, a 6-week, prospective, randomized, double-blind, placebo-controlled study was conducted at eight different veterinary clinics to evaluate the efficacy, safety, and tolerability of NEM® brand eggshell membrane (EM), a novel dietary supplement shown in other species to help maintain healthy joints and connective tissues. SUBJECTS AND METHODS: Fifty-one dogs received oral EM ~13.5 mg/kg (6 mg/lb) or placebo (excipients) once daily for 6 weeks. The primary outcome measure of this study was to evaluate the change in mean joint function following 1 week and 6 weeks of supplementation as determined via the Canine Brief Pain Inventory (CBPI) questionnaire (Q#5-10) in the treatment group versus the placebo group. Secondary outcome measures were for changes in mean CBPI pain and CBPI quality of life, and mean joint pain, mobility and lameness via Veterinary Canine Scoring Assessments (VCSA). A final secondary outcome measure was for a change in serum levels of the cartilage degradation biomarker, c-terminal cross-linked telopeptide of type-II collagen (CTX-II). RESULTS: Supplementation with EM produced a significant treatment response versus placebo at 1 week (20.5% improvement, P=0.028), but fell shy of significance at 6 weeks post-treatment (22.5% improvement) for the primary outcome measure (CBPI Function), despite a sizeable treatment effect. Similarly, there was also a significant treatment response versus placebo at 1 week for CBPI Pain (19.4% improvement, P=0.010), but fell just shy of significance at 6 weeks (22.5% improvement), again despite a sizeable treatment effect. Results were not significant versus placebo at 1 week for CBPI quality of life (14.0% improvement), but produced a significant treatment response by the end of the 6-week study (26.8% improvement, P=0.033). Additionally, EM produced a significant treatment response versus placebo at 6 weeks for VCSA pain (23.6% improvement, P=0.012), but fell shy of significance for VCSA mobility and VCSA lameness (walking & trotting). Serum CTX-II levels in EM-supplemented dogs was significantly improved versus placebo at 6 weeks (47.9% improvement, P=0.018). There were no serious adverse events reported during the study and subject dog owners reported that EM was well tolerated by their pets. CONCLUSION: Supplementation with EM, ~13.5 mg/kg (6 mg/lb) taken once daily, significantly reduced joint pain and improved joint function rapidly (CBPI 1 week) and demonstrated a lasting improvement in joint pain (VCSA 6 weeks) leading to an improved quality of life (CBPI 6 weeks). Moreover, a profound chondroprotective effect was demonstrated following 6 weeks of supplementation with EM (CTX-II).
RESUMO
OBJECTIVE: To determine the clinical usefulness of ultrasonography for diagnosis of meniscal pathology in dogs. STUDY DESIGN: Double-blind prospective study. ANIMALS: Dogs (n=10) with lameness localized to the stifle. MATERIALS AND METHODS: Sonographic examination of each affected stifle was performed by 1 ultrasonographer unaware of specific historical and clinical data for the dog. Sonographic findings were recorded, but not reviewed until study completion. Arthroscopic examination of the affected stifle was performed within 48 hours of ultrasonography by 1 surgeon unaware of ultrasonographic findings. Arthroscopic findings were recorded, but not reviewed until study completion. Two investigators compared the ultrasonographic and arthroscopic findings at study completion to determine the sensitivity, specificity, positive predictive value, and negative predictive value. RESULTS: Two of the 10 dogs had bilateral stifle evaluation. Twenty-four lateral and medial menisci, with normal and abnormal findings, were examined. The sensitivity and specificity for ultrasonographic diagnosis were 90.0% and 92.9%, respectively; positive and negative predictive values were 90.0% and 92.9%, respectively. CONCLUSIONS: Ultrasonography is highly specific and sensitive for diagnosing bucket handle tears of the medial meniscus in dogs. CLINICAL RELEVANCE: Ultrasonographic evaluation of menisci in dogs is a noninvasive method for accurately and efficiently diagnosing pathology, determining the need for surgical intervention, and providing comprehensive information to clients.